Shenyang Xingqi Pharmaceutical Co.,Ltd.

SZSE:300573 Rapport sur les actions

Capitalisation boursière : CN¥15.6b

Shenyang Xingqi PharmaceuticalLtd Bilan de santé

Santé financière contrôle des critères 6/6

Shenyang Xingqi PharmaceuticalLtd has a total shareholder equity of CN¥1.6B and total debt of CN¥230.2M, which brings its debt-to-equity ratio to 14.1%. Its total assets and total liabilities are CN¥2.2B and CN¥558.0M respectively. Shenyang Xingqi PharmaceuticalLtd's EBIT is CN¥389.8M making its interest coverage ratio -190.1. It has cash and short-term investments of CN¥503.3M.

Informations clés

14.1%

Ratio d'endettement

CN¥230.18m

Dette

Ratio de couverture des intérêts-190.1x
Argent liquideCN¥503.31m
Fonds propresCN¥1.63b
Total du passifCN¥558.01m
Total des actifsCN¥2.19b

Mises à jour récentes de la santé financière

Does Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Have A Healthy Balance Sheet?

Jun 28
Does Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Have A Healthy Balance Sheet?

Recent updates

Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/E Is Still On The Mark Following 49% Share Price Bounce

Oct 23
Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/E Is Still On The Mark Following 49% Share Price Bounce

Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing

Sep 08
Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing

With EPS Growth And More, Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Makes An Interesting Case

Aug 19
With EPS Growth And More, Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Makes An Interesting Case

What You Can Learn From Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/S After Its 27% Share Price Crash

Jul 24
What You Can Learn From Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/S After Its 27% Share Price Crash

Does Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Have A Healthy Balance Sheet?

Jun 28
Does Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Have A Healthy Balance Sheet?

Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Is Increasing Its Dividend To CN¥3.00

May 21
Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Is Increasing Its Dividend To CN¥3.00

After Leaping 31% Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Shares Are Not Flying Under The Radar

May 10
After Leaping 31% Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Shares Are Not Flying Under The Radar

We Ran A Stock Scan For Earnings Growth And Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Passed With Ease

May 07
We Ran A Stock Scan For Earnings Growth And Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Passed With Ease

Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Looks Just Right With A 26% Price Jump

Mar 15
Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Looks Just Right With A 26% Price Jump

Analyse de la situation financière

Passif à court terme: 300573's short term assets (CN¥947.7M) exceed its short term liabilities (CN¥483.3M).

Passif à long terme: 300573's short term assets (CN¥947.7M) exceed its long term liabilities (CN¥74.8M).

Historique et analyse du ratio d'endettement

Niveau d'endettement: 300573 has more cash than its total debt.

Réduire la dette: 300573's debt to equity ratio has reduced from 15.9% to 14.1% over the past 5 years.

Couverture de la dette: 300573's debt is well covered by operating cash flow (194.3%).

Couverture des intérêts: 300573 earns more interest than it pays, so coverage of interest payments is not a concern.

Bilan

Découvrir des entreprises saines

7D

1Y

7D

1Y

7D

1Y